Wed, Oct 22, 2014, 6:00 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Stellar Biotechnologies, Inc. Message Board

  • kenticus_maximus kenticus_maximus Nov 8, 2013 10:47 AM Flag

    A Dose of Reality

    Just a little misinformation out there. Stellar does have revenue: about 300k in the last twelve months. Quarterly revenue growth year-over-year is about 70%. 300k isn't much, but it isn't zero, and it is headed in the right direction. Stellar does have assets: the patents on their technology represent valuable intellectual property. Stellar is positioning itself to take advantage of their expertise. But don't take my--or anyone else's word for it--please do your own research; consider the agenda of others; and please don't feed the trolls.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They are selling a new product Anti KLH Elisa test kits... it could accelerate the revenue growth rate.

      Also, the Keyhole limpets in their tanks can producie 5 kilos of KLH... they are introducing nicely and they aim a capacity of 20 Kilos ... (at 50 K$ a gram)... but that asset is not in the books

      Sentiment: Strong Buy

    • I like to compare Stellar Biotechnologies to what happen during The California Gold Rush.
      You see we are in a New Gold Rush, but it’s a RUSH to find a CURE for CANCER.

      The General Stores supplied the Miners the tools to find Gold, and Stellar Biotechnologies is supplying the tools (KLH) to find a CURE for CANCER...

      Some Miners made a living; many went broke, but the General stores that sold the tools made money.
      Stellar Biotechnologies is the NEW GENERAL STORE for the BIOTECH MINERS.

      Sentiment: Hold

    • good info

 
SBOTF
1.25-0.16(-11.35%)Oct 22 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.